1LEVI F,MISSET J L,BRIENZA S,et al. A chronopharmacologic phase II clinical trial with 5-fluorouracil,folinie acid,and oxaliplatin using an ambulatory muhichannel programmable pump. High anfitumor effectiveness against metastatic colorectal cancer[J]. Cancer, 1992,69(4) :893-900.
2LEONARD G D,WRISAT M A,QUINN M G,et al. Survey of oxaliplatin-associatcd ncurotoxicity using an interview-based questionnaire in patients with metastatic coloreetal cancer[J]. BMC Cancer,2005,1 (5) : 116-124.
3DE VITA F,ORDITURA M,MATANO E,et al. A phase lI study ofbiweekly axaliplatin plus infusion 5-nuorouracil and folinic acid (FOLFOX-4)as first-line treatment d advanced gastric cancer patients[J]. Br J Cancer,2005,92(9) : 1644-1649.
4OCEAN A J, VAHDAT L T. Chemotherapy-induced peripheral neurupathy : pathogenesis and emerging therapies [J ]. Support Care Cancer,2004,12(9) :619-625.
5VON DELIUS S ,ECKEL F, WAGENPFEIL S. Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer:final results of a randomlsed, controlled,multicenter phase II atudy [J]. InveatNew Drugs, 2007,25 (2) : 173-180.
6GAMELIN L, BOISDRON-CELLEI M, DELVA R, et al. A retrospectivestudy of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced eolorectal cancer[J]. Clin Cancer Res,2004,10:4055-4061.
